S&P 500: 662.29 -0.6% NASDAQ 100: 593.72 -0.6% Dow Jones: 466.41 -0.2%

Haemonetics Corporation

HAE Healthcare
$59.92 +$0.43 (0.72%)
Market Cap: $2.78 B
Gurus Holding
5
Popularity Rank
#1904
% of Shares Held
8.94%
Net Activity (Q4 2025)
+$65.02 M

Guru Ownership Trend

Guru Analysis for Haemonetics Corporation (HAE)

Haemonetics Corporation (HAE), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q4 2025, a total of 5 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $248.82 M.

Top institutional holders include Cliff Asness and Steven Cohen.

Institutional sentiment is currently Strongly Bullish. This is evidenced by a $65.02 M net inflow during the quarter.

Recent activity highlights Steven Cohen who dramatically increased their stake. Conversely, Chuck Royce reduced exposure by 89.8%.

Key Holders

Top 5 by Value

$253.52 M
$68.4 M
$5.73 M
$1.51 M

Top 5 by Conviction

Recent Activity Breakdown (Q4 2025)

+$151.51 M
Total Buy Value
New Buys 1
Additions 2
-$86.49 M
Total Sell Value
Reductions 2
Sold Out 3

Guru Consensus (Q4 2025)

Based on recent activity
Net Sellers
5
Net Buyers
3

FAQs for Haemonetics Corporation (HAE)

Major holders include Cliff Asness ($253.52 M), Steven Cohen ($68.4 M), Chuck Royce ($5.73 M). According to the latest reported data, 5 tracked investment managers collectively hold approximately 4.15 M shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $65.02 M, with 3 managers increasing positions and 5 managers reducing holdings.

During the most recent reporting period, 2 managers trimmed their positions, while 3 fully exited HAE. The total reported sell value was $86.49 M.

Yes, 1 managers opened new positions in HAE, and 2 increased their existing holdings. The total reported buy value was $151.51 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.13% Add 48.6% 3,163,104 $253.52 M Q4 2025
0.08% Add 1882.3% 853,379 $68.4 M Q4 2025
0.06% Reduce -89.8% 71,475 $5.73 M Q4 2025
0.01% New Buy 45,776 $3.67 M Q4 2025
0.01% Reduce -17.9% 18,814 $1.51 M Q4 2025
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form